PX1 Research is a premier USA-based supplier of high-purity Chonluten (Glu-Asp-Arg) engineered specifically for in vitro and preclinical research into inflammatory response control, bronchial cell dynamics, and gene expression modulation.
PX1 Research is a premier USA-based supplier of high-purity Chonluten (Glu-Asp-Arg) engineered specifically for in vitro and preclinical research into inflammatory response control, bronchial cell dynamics, and gene expression modulation.
As a specialized inflammatory response control Chonluten supplier, PX1 Research provides research-grade Glu-Asp-Arg tripeptide synthesized under strict quality controls for academic and institutional laboratories. Every lot of our high-purity Chonluten undergoes rigorous third-party verification, including reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS), ensuring greater than 99% purity and documented endotoxin control.
Researchers seeking consistent material for investigating pulmonary tissue homeostasis, cytokine signaling pathways, and cell-culture inflammatory models rely on PX1 for lot-to-lot reproducibility, rapid US-based shipping from California and Arizona facilities, and complete analytical transparency via verified Certificates of Analysis (COAs).
Chonluten is a synthetic short bioregulatory tripeptide consisting of the amino acid sequence L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg, or EDG). Identified within the broader class of Khavinson peptide bioregulators, Chonluten exhibits targeted activity in epithelial and mucosal cell lines. In preclinical settings, short peptides of this class are investigated for their capacity to cross nuclear membranes and interact directly with nucleosomes and specific DNA promoter regions.
In vitro models suggest that Glu-Asp-Arg can alter chromatin structure, influencing histone modifications and modulating the transcriptional efficiency of genes associated with cellular repair and inflammatory signaling cascades. By examining the bioregulatory peptide mechanisms, investigators evaluate how low-molecular-weight sequence motifs regulate cellular responses to oxidative stress, hypoxia, and pro-inflammatory stimuli.
Preclinical investigations using rodent models and primary tissue cultures have highlighted Chonluten's role in modulating local inflammatory responses within bronchial and alveolar tissues. Research models evaluating acute respiratory inflammation indicate that administration of Glu-Asp-Arg is correlated with reductions in pro-inflammatory cytokine expression, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6).
Furthermore, animal studies demonstrate that Chonluten exposure during challenged states assists in preserving surfactant synthesis and stabilizing epithelial barrier integrity. Investigators utilizing our catalog of research peptides often measure markers of neutrophil infiltration, myeloperoxidase (MPO) activity, and reactive oxygen species (ROS) generation to detail the exact downstream pathways through which Glu-Asp-Arg attenuates tissue destruction.
Beyond surface receptor binding, the structural properties of Chonluten allow it to participate in direct genomic interactions within cell culture assays. Fluorescence spectroscopy and circular dichroism studies indicate that Glu-Asp-Arg binds specifically to double-stranded DNA in the major groove, demonstrating site-specificity for sequences enriched in cytosine-guanine clusters.
This nuclear localization triggers changes in gene expression profiles without disrupting genetic sequence integrity. In vitro assays using human bronchial epithelial cells (e.g., BEAS-2B models) indicate that Chonluten upregulates anti-inflammatory signaling molecules while downregulating nuclear factor kappa B (NF-κB) nuclear translocation. Such data make Chonluten a critical compound for evaluating long-term epigenetic regulation of cellular stress responses.
When designing protocols focused on tissue recovery and inflammatory control, researchers frequently compare Chonluten against other bioregulatory and cytoprotective peptides. While Chonluten specifically targets bronchial epithelial signaling and nuclear transcription, compounds like Bronchogen offer complementary insights into pulmonary fibroblast dynamics. Similarly, researchers evaluating systemic cellular recovery protocols often benchmark Chonluten against the BPC-157 research profile for endothelial cell stabilization or utilize Thymosin Alpha-1 assays to compare broad-spectrum T-cell maturation and immune balance.
Understanding these distinctions allows investigators to select the precise molecular tool required for their specific assay—whether evaluating direct epigenetic modulation with short tripeptides like Chonluten or broader systemic signaling cascades via larger peptide motifs.
To generate reliable, reproducible data, laboratories require compounds devoid of sequence errors, truncation products, or residual synthesis reagents. PX1 Research adheres to stringent analytical validation protocols for every batch of Chonluten produced. Every lot undergoes analytical testing in an ISO 17025 accredited facility using High-Performance Liquid Chromatography (RP-HPLC) coupled with Electrospray Ionization Mass Spectrometry (ESI-MS).
Our analytical thresholds guarantee a minimum purity of 99.0%, with full mass identity confirmation matching the theoretical molecular weight of Glu-Asp-Arg. Furthermore, given that bacterial endotoxins can confound immune and inflammatory assays, PX1 subjects all Chonluten lots to Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin content remains strictly below <0.01 EU/mg. Batch-specific COAs are downloadable directly through the PX1 research library.
For optimal laboratory utility, Chonluten is supplied as a lyophilized white powder under argon packaging. Proper reconstitution techniques are vital to maintain the physical and chemical stability of the tripeptide in experimental setups. Investigators are advised to follow standard aseptic techniques when preparing stock solutions for in vitro or preclinical models.
Reconstitution should ideally be performed using sterile, bacteriostatic, or endotoxin-free water depending on the downstream assay requirements. Due to its hydrophilic amino acid composition (Glu, Asp, Arg), Chonluten dissolves rapidly in aqueous buffers at neutral pH without requiring organic cosolvents. After reconstitution, stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent degradation caused by repeated freeze-thaw cycles.
Maintaining long-term peptide stability is critical for multi-phase laboratory studies. Lyophilized Chonluten should be stored in a freezer at -20°C or -80°C upon receipt, protected from light and moisture. Under these conditions, the unconstituted peptide maintains chemical stability for up to 24 months without measurable degradation.
Once dissolved in aqueous buffers, reconstituted Chonluten stock solutions are stable at 4°C for up to 7 days. For extended experimental timelines, reconstituted aliquots must be frozen at -80°C, where stability is preserved for up to 6 months. Researchers should avoid using non-frost-free freezers to prevent temperature fluctuations that induce peptide aggregation.
PX1 Research supports university departments, biotechnology organizations, and independent research institutions with dependable sourcing for specialized bioregulatory peptides. Operating out of dual fulfillment hubs in California and Arizona, PX1 guarantees same-day shipping on all business days, reducing transit times and preserving cold-chain integrity.
Institutions requiring high-volume orders or customized batch specifications can utilize our dedicated wholesale institutional account portal. With full batch traceability, cGMP-compliant manufacturing processes, and comprehensive documentation, PX1 Research stands as the premier USA supplier for inflammatory response control Chonluten and advanced peptide compounds.
What is Chonluten (Glu-Asp-Arg) and how is it utilized in research?
Chonluten is a synthetic tripeptide (Glu-Asp-Arg) studied in vitro and in animal models for its role in cellular bioregulation, epigenetic gene expression, and modulating inflammatory cytokine responses in bronchial and epithelial cell lines.
How does PX1 Research verify the purity of its Chonluten supply?
Every lot of Chonluten undergoes analytical testing via RP-HPLC and mass spectrometry in ISO 17025 accredited laboratories to confirm sequence identity and achieve purity levels exceeding 99%.
What are the endotoxin limits for PX1 Chonluten?
PX1 Research subjects all peptide lots to LAL assay testing, ensuring endotoxin levels are verified at <0.01 EU/mg to prevent confounding cell culture or inflammatory experimental outcomes.
How should lyophilized Chonluten be reconstituted for cell culture assays?
Reconstitute lyophilized Chonluten using sterile, endotoxin-free water or PBS under a laminar flow hood. Gentle swirling is recommended; avoid high-speed vortexing to maintain molecular integrity.
What compounds are comparable to Chonluten in inflammatory research?
In tissue recovery and inflammatory studies, Chonluten is often researched alongside Bronchogen (for lung tissue models), BPC-157 (for tissue cytoprotection), and Thymosin Alpha-1 (for immune system signaling).
What is the recommended long-term storage condition for Chonluten?
Lyophilized Chonluten should be stored at -20°C or -80°C away from light. Reconstituted solutions should be stored in single-use aliquots at -80°C to prevent degradation from freeze-thaw cycles.
Where is PX1 Research located and how fast do products ship?
PX1 Research is based in the USA with distribution facilities in California and Arizona. Orders placed Monday through Friday ship same-day for rapid laboratory delivery.
Can academic institutions set up bulk or wholesale supply accounts for Chonluten?
Yes, PX1 Research provides dedicated institutional and wholesale accounts for high-volume lab orders, offering volume tier pricing and lot-reserved inventory.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.